Post-approval studies (Phase 4)WithdrawnNCT05355350
What this trial is testing
PipEracillin/Tazobactam Versus mERoPENem for Treatment of AmpC Producing Blood Stream Infections
Who this might be right for
Beta Lactam Resistant Bacterial InfectionEnterobacteriaceae InfectionsBacteremia
Rambam Health Care Campus